Nurse-Led Mobile App Effect on Symptom Management for Breast Cancer Patients After Surgery

July 10, 2024 updated by: Aydanur Aydin, Gümüşhane Universıty

Nurse-Led Mobile App Effect on Symptom Management for Breast Cancer Patients After Surgery: A Quasi-Experimental Study

Background: The use of the Nurse-Led Mobile App (NL-Mapp) is a current and important option for educating patients about the symptoms that may arise from breast cancer surgery.

Introduction: Given the precise information and counseling services offered to breast cancer patients, NL-Mapp is considered an appropriate choice to support postoperative self-care.

Methods: This quasi-experimental study aimed to determine the impact of NL-Mapp on breast cancer patients after surgery. The study included 45 patients in the intervention group and 45 patients in the control group. First, NL-Mapp was developed by the research team. Patients were then taught how to use the app to manage their symptoms after breast cancer surgery, and online counseling was provided for patients' questions. The intervention started before surgery, and follow-up visits were made before discharge and in the first month.

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

45

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Gumushane, Turkey
        • Gumushane University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Speaking the national language,
  • The presence of primary breast cancer,
  • The utilization of a smartphone for a minimum of one year,
  • An age of 20 years

Exclusion Criteria:

  • An uncontrollable medical problem,
  • Having speech problems,
  • Having hearing problems,
  • Vision impairment,
  • A psychiatric diagnosis/ongoing treatment
  • Previous treatment due to a different type of cancer
  • Rheumatological diseases,
  • Fractures,
  • Health problems leading to joint limitation,
  • Amputation

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention
Mobile applicaiton
No Intervention: Control

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Function of the affected arm
Time Frame: three months
ASES Shoulder Rating Scale
three months
Body image and sexual adjustment scale
Time Frame: three months
Sexual Adjustment and Body Image Scale
three months
Pain scale
Time Frame: three months
Visual Analog Scale
three months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Quality of life scale
Time Frame: one year
Functional Assessment of Cancer Therapy-Breast
one year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2019

Primary Completion (Actual)

January 1, 2020

Study Completion (Actual)

January 1, 2021

Study Registration Dates

First Submitted

March 1, 2024

First Submitted That Met QC Criteria

July 10, 2024

First Posted (Actual)

July 17, 2024

Study Record Updates

Last Update Posted (Actual)

July 17, 2024

Last Update Submitted That Met QC Criteria

July 10, 2024

Last Verified

July 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • GumushaneUni1

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Mobile Health

Clinical Trials on NL-Mapp

Subscribe